CVR number 41657219
Industry 32.5000 Manufacture of medical and dental instruments and supplies

ZenzeTech ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2018
N/A
2019
N/A
2020
2021/3
2021
2022/3
2022
2023/3
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 15.5% 21.2% 15.5%  
Credit score (0-100)  0 0 12 4 12  
Credit rating  N/A N/A BB B BB  
Credit limit (kDKK)  0.0 0.0 0.0 -0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
N/A
2019
N/A
2020
2021/3
2021
2022/3
2022
2023/3
Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 -142 -1,324 148  
EBITDA  0.0 0.0 -265 -1,742 -1,095  
EBIT  0.0 0.0 -265 -1,742 -1,095  
Pre-tax profit (PTP)  0.0 0.0 -269.5 -1,747.2 -1,102.8  
Net earnings  0.0 0.0 -244.9 -1,477.5 -979.1  
Pre-tax profit without non-rec. items  0.0 0.0 -269 -1,747 -1,103  
 
See the entire income statement

Balance sheet (kDKK) 
2018
N/A
2019
N/A
2020
2021/3
2021
2022/3
2022
2023/3
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 0.0 795 -682 1,338  
Interest-bearing liabilities  0.0 0.0 6.3 1,148 1.9  
Balance sheet total (assets)  0.0 0.0 814 589 1,560  
Net Debt  0.0 0.0 -691 956 -1,078  
 
See the entire balance sheet

Volume 
2018
N/A
2019
N/A
2020
2021/3
2021
2022/3
2022
2023/3
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 -142 -1,324 148  
Gross profit growth  0.0% 0.0% 0.0% -833.9% 0.0%  
Employees  0 0 1 2 4  
Employee growth %  0.0% 0.0% 0.0% 100.0% 100.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 814 589 1,560  
Balance sheet change%  0.0% 0.0% 0.0% -27.6% 164.7%  
Added value  0.0 0.0 -264.8 -1,742.0 -1,094.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 -1.0 -2.0 -3.0  

Profitability 
2018
N/A
2019
N/A
2020
2021/3
2021
2022/3
2022
2023/3
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 186.8% 131.6% -739.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% -32.5% -167.0% -77.3%  
ROI %  0.0% 0.0% -33.0% -178.7% -88.0%  
ROE %  0.0% 0.0% -30.8% -213.5% -101.6%  

Solidity 
2018
N/A
2019
N/A
2020
2021/3
2021
2022/3
2022
2023/3
Equity ratio %  0.0% 0.0% 97.6% -53.7% 85.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 260.9% -54.9% 98.5%  
Gearing %  0.0% 0.0% 0.8% -168.2% 0.1%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 147.2% 0.9% 1.4%  

Liquidity 
2018
N/A
2019
N/A
2020
2021/3
2021
2022/3
2022
2023/3
Quick Ratio  0.0 0.0 42.1 2.2 7.0  
Current Ratio  0.0 0.0 42.1 2.2 7.0  
Cash and cash equivalent  0.0 0.0 697.3 192.5 1,080.4  

Capital use efficiency 
2018
N/A
2019
N/A
2020
2021/3
2021
2022/3
2022
2023/3
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 795.1 317.5 1,338.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2018
N/A
2019
N/A
2020
2021/3
2021
2022/3
2022
2023/3
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 -265 -871 -274  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 -265 -871 -274  
EBIT / employee  0 0 -265 -871 -274  
Net earnings / employee  0 0 -245 -739 -245